RD – NEPHROLOGIE was founded by its president, Àngel Argilés, research director, who was seconded from the CNRS to create the company in accordance with the article 25.1 of the French law n° 99-587 of July 12, 1999, on innovation and research. Its objectives are research, development and transfer in the biomedical field and more particularly in nephrology.
RD – NEPHROLOGIE provides expertise in research and development in the context of renal pathology. It markets R&D services to pharmaceutical industries developing new products (co-development) as well as an expertise in clinical research, evaluation of therapeutic innovations and fundamental biology, in the context of projects co-developed with pharmaceutical industries and research laboratories.
RD – Nephrologie is composed of seven members participating in the research